The Accuracy of Genetic Testing in Diagnosing Common Metabolic and Heart Diseases
Overview
Objectives/Goals The objective of this project was to discover the accuracy and usefulness of genetic testing to be used in private medical offices. Methods/Materials Ten individuals were selected from a private internal medicine practice to be genetically tested for twenty-five diseases. The researcher made comparisons between the patients# past medical histories and the genetic test results to determine the accuracy of the genetic tests. The second part of the experiment involved performing conventional testing on the patients to rule out the diseases that were not found in their past medical histories but were above the average lifetime risk in their genetic test results. Then, patients were provided with personalized protocols to prevent their likelihood for obtaining diseases. Some of the materials utilized in this project were genetic test kits, lancets, alcohol swabs, EKG machine, exercise treadmill machine, thallium stress test machine, echo stress test machine, Sequenom massarray chip, Sequenom massarray machine, thermalcycler, and a nanodispenser. Results In the final analysis, macular degeneration resulted in being a disease that was most accurate, 100%, with aneurysm following, 90%. Type 2 diabetes and peripheral vascular disease were both 80% accurate, and in both diseases the genetic test was inaccurate in identifying the controls. Then, osteoarthritis and migraine were both 70% accurate. Type 1 diabetes was 70% accurate, failing to identify all the cases, while obesity, which was 60% accurate, failed to identify some of the controls. Lastly, coronary heart disease was the least accurate, 20%. Conclusions/Discussion Genetic testing was not 100% accurate in distinguishing the cases and controls for some diseases; however, genetic testing can be utilized as a tool to aid physicians in the diagnosis of diseases, the determination of the patients# conditions, and the prevention of future diseases. We are entering an era of personal genome testing at the nucleotide level. By using the clinician#s armamentarium, personal genome testing will change the field of medicine in a propitious way, allowing physicians to pinpoint their patients# diseases.
Summary statement
This study involved discovering the accuracy of genetic testing in distinguishing the cases and controls of common metabolic and heart diseases, as well as finding the benefits of utilizing genetic testing in private medical offices.
Help received
Joseph Nadeau PhD. for project direction; George John M. Jr. M.D. FACP for supervising genetic testing; DNA Specialist Dan Slowinski (GTL Lab.) for analyzing blood samples; Vashaspathi Palakodeti M.D. (IV Cardiology) for performing heart examinations and teaching me the procedures.
Competition history
- CSEF 2012
Resources
Related projects
CSEF · 2016
Genomic Reliability of Consumer Tests
ISEF · 2015
IntelliGenome: Using Artificial Intelligence to Diagnose Genetic Diseases on the Genomic Level
CSEF · 2010
Novel Genetics-Based Early Disease Detection Using Ontology-Driven Microarray Semantics with Optimized Mass Spectrometry
CSEF · 2019
Identification of Novel Biomarkers for the Early Diagnosis of Acute Myocardial Infarction
CSEF · 2016
Pharmacogenectics, Informatics, and Prescription Change
CSEF · 2015
False Positive and False Negative Paradox
CSEF · 2016
Developing a Low Cost Noninvasive Prenatal Diagnosis for Genetic Disorders
CSEF · 2004
GENEalogy: Tracing a Mutant Gene through My Family Line
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects